ES2192704T3 - Innovadoras composiciones farmaceuticas. - Google Patents

Innovadoras composiciones farmaceuticas.

Info

Publication number
ES2192704T3
ES2192704T3 ES97950098T ES97950098T ES2192704T3 ES 2192704 T3 ES2192704 T3 ES 2192704T3 ES 97950098 T ES97950098 T ES 97950098T ES 97950098 T ES97950098 T ES 97950098T ES 2192704 T3 ES2192704 T3 ES 2192704T3
Authority
ES
Spain
Prior art keywords
compositions
pharmaceutical compositions
innovative pharmaceutical
conjugate
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97950098T
Other languages
English (en)
Inventor
Matteo Ghirri
Marco Zema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adare Pharmaceuticals SRL
Original Assignee
Eurand International SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand International SpA filed Critical Eurand International SpA
Application granted granted Critical
Publication of ES2192704T3 publication Critical patent/ES2192704T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVAS COMPOSICIONES, EN PARTICULAR A COMPOSICIONES QUE COMPRENDEN CALCITONINA O UN FRAGMENTO O UN CONJUGADO DE LA MISMA Y PROCEDIMIENTOS PARA PREPARAR LAS COMPOSICIONES. LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES ORALES QUE COMPRENDEN LAS COMPOSICIONES Y A FORMULACIONES AUTOESTABLES DE CALCITONINA O DE UN FRAGMENTO O DE UN CONJUGADO DE LA MISMA.
ES97950098T 1996-11-07 1997-11-05 Innovadoras composiciones farmaceuticas. Expired - Lifetime ES2192704T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9623205.3A GB9623205D0 (en) 1996-11-07 1996-11-07 Novel pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2192704T3 true ES2192704T3 (es) 2003-10-16

Family

ID=10802593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97950098T Expired - Lifetime ES2192704T3 (es) 1996-11-07 1997-11-05 Innovadoras composiciones farmaceuticas.

Country Status (15)

Country Link
US (1) US6352974B1 (es)
EP (1) EP0966299B1 (es)
JP (1) JP2001511114A (es)
AR (1) AR010554A1 (es)
AT (1) ATE232397T1 (es)
AU (1) AU5317598A (es)
CA (1) CA2270927A1 (es)
CO (1) CO4930284A1 (es)
DE (1) DE69719083T2 (es)
DK (1) DK0966299T3 (es)
ES (1) ES2192704T3 (es)
GB (1) GB9623205D0 (es)
PT (1) PT966299E (es)
WO (1) WO1998019697A2 (es)
ZA (1) ZA9710006B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3556400A (en) 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
EP2206720A1 (en) * 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US7713932B2 (en) * 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
MXPA06000807A (es) * 2003-07-23 2006-08-23 Novartis Ag Uso de calcitonina en osteoartritis.
WO2006124047A2 (en) * 2004-08-13 2006-11-23 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7581403B2 (en) * 2005-04-15 2009-09-01 Deeks Daniel H Energy storage arrangement
AU2006236006B2 (en) * 2006-04-13 2012-09-06 The University Of Queensland Cyclised a-conotoxin peptides
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
JP5966202B2 (ja) * 2007-02-20 2016-08-10 アラガン ファーマシューティカルズ インターナショナル リミテッド 安定な消化酵素組成物
US20090117180A1 (en) * 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
ES2657673T3 (es) 2010-10-01 2018-03-06 Aptalis Pharma Limited Formulaciones recubiertas entéricas de pancrelipasa, de baja intensidad
CA2843556A1 (en) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
CA2920844A1 (en) 2013-08-09 2015-02-12 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
DE4119140C2 (de) * 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤

Also Published As

Publication number Publication date
EP0966299A2 (en) 1999-12-29
ZA9710006B (en) 1999-06-05
CO4930284A1 (es) 2000-06-27
DK0966299T3 (da) 2003-06-02
PT966299E (pt) 2003-06-30
EP0966299B1 (en) 2003-02-12
WO1998019697A3 (en) 1998-07-16
JP2001511114A (ja) 2001-08-07
ATE232397T1 (de) 2003-02-15
CA2270927A1 (en) 1998-05-14
DE69719083D1 (de) 2003-03-20
DE69719083T2 (de) 2003-12-18
US6352974B1 (en) 2002-03-05
AR010554A1 (es) 2000-06-28
GB9623205D0 (en) 1997-01-08
AU5317598A (en) 1998-05-29
WO1998019697A2 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
ES2192704T3 (es) Innovadoras composiciones farmaceuticas.
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
ES2160145T3 (es) Composicion farmaceutica para la administracion oral de flavonoides.
BR9611802A (pt) Composições farmacêuticas
ES2194107T3 (es) Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales.
TR199901077A3 (tr) Ispençiyari formülasyonlar.
EE03692B1 (et) 19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
ID18352A (id) Komposisi-komposisi farmasi
EE03664B1 (et) Farmatseutilised aerosoolkompositsioonid
DK0971717T3 (da) Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
FI991302A7 (fi) Parannetut farmaseuttiset koostumukset
ES2174199T3 (es) Utilizacion de un poliholosido para estimular las defensas inmunitarias.
BR0114912A (pt) Kahalalide f
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
PT868911E (pt) Formulacoes de rapamicina para administracao oral
ID16781A (id) Formulasi-formulasi farmasi
AR007165A1 (es) Composición farmacéutica para uso oral que contiene diclofenac.
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
DZ1926A1 (fr) Formulations pharmaceutiques.
ES2174196T3 (es) Utilizacion de ceramida para el tratamiento de las uñas.
ATE305517T1 (de) Neurotrypsin
PT941100E (pt) Composicoes farmaceuticas
PT939083E (pt) Complexos de ferro-succinilcaseina procedimento para sua preparacao e suas composicoes farmaceuticas
ATE201996T1 (de) Hirudin enthaltende pharmazeutische zusammensetzungen